open access

Vol 17, No 3 (2021)
Research paper
Published online: 2021-02-19
Get Citation

Radiotherapy in Ewing’s Sarcoma Family Tumor — experience from North-East India

Faridha Jane Momin, Mouchumee Bhattacharyya, Subhalakshmi Saikia, Rakesh Kumar Mishra, Jyotiman Nath, Gautam Sarma, Apurba Kumar Kalita, Manoj Kalita, Partha Pratim Medhi
DOI: 10.5603/OCP.2021.0008
·
Oncol Clin Pract 2021;17(3):103-111.

open access

Vol 17, No 3 (2021)
ORIGINAL ARTICLES
Published online: 2021-02-19

Abstract

Introduction. The multimodality management of Ewing’s Sarcoma Family Tumors (ESFT) consists of neoadjuvant chemotherapy followed by local treatment: surgery, radiotherapy (RT) or a combination of both. The objectives of this study were to analyze disease control and overall survival in patients receiving radiotherapy as local treatment, as part of multimodality management of ESFT at our institute over a period of seven years.

Material and methods. This is a retrospective single institutional study. Hospital records were searched for patients with ESFT who received radiotherapy from January, 2012 to December, 2018. Forty-nine patients were found eligible and evaluated with respect to prognostic factors, treatment-related factors and outcomes. Time to event was measured from the date of diagnosis and survival curves were estimated by Kaplan-Meier method and log-rank test for comparison.

Results. Median follow up for patients was 18 months (range 3–81 months). Local failure/relapse was associated with worse survival. Five-year local control was 79.1% and overall survival 51.2% in the analyzed cohort. Local control did not differ significantly based on prognostic variables or treatment characteristics. Combined surgery and radiotherapy as local treatment along with good response to neoadjuvant chemotherapy were associated with significant improvement in overall survival (p-value < 0.05).

Conclusions. Combined modality local treatment with surgery and radiotherapy along with a favorable response to neoadjuvant chemotherapy are associated with improved survival in ESFT. For unresectable tumors, radiotherapy alone remains the optimum local treatment, albeit with inferior survival outcomes.

Abstract

Introduction. The multimodality management of Ewing’s Sarcoma Family Tumors (ESFT) consists of neoadjuvant chemotherapy followed by local treatment: surgery, radiotherapy (RT) or a combination of both. The objectives of this study were to analyze disease control and overall survival in patients receiving radiotherapy as local treatment, as part of multimodality management of ESFT at our institute over a period of seven years.

Material and methods. This is a retrospective single institutional study. Hospital records were searched for patients with ESFT who received radiotherapy from January, 2012 to December, 2018. Forty-nine patients were found eligible and evaluated with respect to prognostic factors, treatment-related factors and outcomes. Time to event was measured from the date of diagnosis and survival curves were estimated by Kaplan-Meier method and log-rank test for comparison.

Results. Median follow up for patients was 18 months (range 3–81 months). Local failure/relapse was associated with worse survival. Five-year local control was 79.1% and overall survival 51.2% in the analyzed cohort. Local control did not differ significantly based on prognostic variables or treatment characteristics. Combined surgery and radiotherapy as local treatment along with good response to neoadjuvant chemotherapy were associated with significant improvement in overall survival (p-value < 0.05).

Conclusions. Combined modality local treatment with surgery and radiotherapy along with a favorable response to neoadjuvant chemotherapy are associated with improved survival in ESFT. For unresectable tumors, radiotherapy alone remains the optimum local treatment, albeit with inferior survival outcomes.

Get Citation

Keywords

Ewing’s Sarcoma; PNET; ESFT; radiotherapy; surgery; chemotherapy

About this article
Title

Radiotherapy in Ewing’s Sarcoma Family Tumor — experience from North-East India

Journal

Oncology in Clinical Practice

Issue

Vol 17, No 3 (2021)

Article type

Research paper

Pages

103-111

Published online

2021-02-19

DOI

10.5603/OCP.2021.0008

Bibliographic record

Oncol Clin Pract 2021;17(3):103-111.

Keywords

Ewing’s Sarcoma
PNET
ESFT
radiotherapy
surgery
chemotherapy

Authors

Faridha Jane Momin
Mouchumee Bhattacharyya
Subhalakshmi Saikia
Rakesh Kumar Mishra
Jyotiman Nath
Gautam Sarma
Apurba Kumar Kalita
Manoj Kalita
Partha Pratim Medhi

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl